Long-term outcomes with a glistening-free hydrophobic IOL
Session Details
Session Title: Pseudophakic IOLs: Monofocal/Accommodative
Session Date/Time: Tuesday 13/09/2016 | 16:30-18:00
Paper Time: 16:54
Venue: Hall C2
First Author: : C.Chassain FRANCE
Co Author(s): :
Abstract Details
Purpose:
To evaluate the safety and incidence of glistening and posterior capsule opacification (PCO) in a series of consecutive eyes following implantation of a new blue light-filtering hydrophobic acrylic intraocular lens (IOL)
Setting:
Service d'Ophtalmologie, Clinique Beausoleil, Avenue de Lodève, Montpellier, France
Methods:
This study included a series of eyes that underwent routine cataract surgery followed by PODEye monofocal IOL (PhysIOL SA, Liege, Belgium) implantation. Safety was assessed by visual acuity (VA), rotational stability and centration, and postoperative medication. The incidence and severity of glistenings was evaluated with a slitlamp; glistenings and PCO were subjectively grade. Nd:YAG capsulotomy rates were retrospectively evaluated at 5 years postoperative and findings compared with patients implanted with different models of the AcrySof IOL. The Nd:YAG rate of a second series of consecutive eyes, also implanted with the PODeye IOL, was retrospectively analyzed at 3 years postoperative.
Results:
In the first PODEye group (n=66), 43 eyes were examined at 3 years postoperative; the median postoperative VA (decimal) was 1.0. The IOL was stable across all axes. Glistenings were absent in the PODEye group but present in the Acrysof group; 1/43 eyes had Nd:YAG capsulotomy after 3 years and 5 had Nd:YAG capsulotomy after 5 years; 66% had a grade 0 opacification after 3 years. In the second PODEye group (n=543), 13 eyes had a YAG capsulotomy 3 years postoperative.
Conclusions:
The PODEye IOL was safe and stable with a low incidence of PCO. Glistenings were not found with the blue light-filtering hydrophobic acrylic IOL.
Financial Disclosure:
... gains financially from product or procedure presented
